Featured Research

from universities, journals, and other organizations

Enzyme's Cancer-promoting Activities Linked To Inactivation Of 'Genome Guardian'

Date:
October 16, 2007
Source:
Baylor College Of Medicine
Summary:
The enzyme WIP1 becomes cancer-causing when there is too much of it, preventing the p53 gene from protecting the genome against dangerous DNA mutations, according to new research. The gene p53 prevents a damaged or stressed cell from dividing. When these damaged cells cannot reproduce, they cannot repeat the genetic changes that have led to their damage.

The enzyme WIP1 (wild-type p53-induced phosphatase one) becomes cancer-causing when there is too much of it, preventing the p53 gene from protecting the genome against dangerous DNA mutations, said Baylor College of Medicine researchers in a report that appears in the journal Cancer Cell.

The gene p53 prevents a damaged or stressed cell from dividing, said Dr. Lawrence A. Donehower, professor of molecular virology and microbiology and molecular and cellular biology at BCM. When these damaged cells cannot reproduce, they cannot repeat the genetic changes that have led to their damage. In the research described in this report, he and his colleagues describe how WIP1 interacts with both p53 and its off-switch, a protein called Mdm2.

"In the cell, p53 helps to repair cell damage by eliminating those cells with damaged or mutated DNA," said Donehower. "Once that task is accomplished, Mdm2 builds up and turns off p53, bringing the situation back to normal."

"After p53 has finished its activity, WIP1 removes a phosphate molecule, which allows Mdm2 to degrade the p53," said Donehower. However, when WIP1 is overexpressed, meaning there is extra enzyme in the cell, it stabilizes Mdm2, increasing the rate of p53 degradation.

The fact that WIP1 is increased in some breast, ovarian and brain tumors buttresses its role in causing cells to become cancerous, said Donehower.

"In some tumor types, if you have WIP1 overexpression, the prognosis is poorer than if you don't," he said. In fact, tumors with high levels of WIP1 rarely have mutations in p53, he said.

"If you have a lot of this protein in the cell, it's continually knocking down p53. The tumor doesn't need to mutate the p53 gene," he said.

Others who took part in this research include Xiongbin Lu, Ou Ma and Thuy-Ai Nguyen, all of BCM, Stephen N. Jones of the University of Massachusetts Medical School in Worcester, and Moshe Oren of the Weizmann Institute in Rehovot, Israel.

Funding for this research came from the National Institutes of Health, the A-T Children's Project and the U.S. Department of Defense Breast Cancer Research Program.


Story Source:

The above story is based on materials provided by Baylor College Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Baylor College Of Medicine. "Enzyme's Cancer-promoting Activities Linked To Inactivation Of 'Genome Guardian'." ScienceDaily. ScienceDaily, 16 October 2007. <www.sciencedaily.com/releases/2007/10/071015215101.htm>.
Baylor College Of Medicine. (2007, October 16). Enzyme's Cancer-promoting Activities Linked To Inactivation Of 'Genome Guardian'. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/10/071015215101.htm
Baylor College Of Medicine. "Enzyme's Cancer-promoting Activities Linked To Inactivation Of 'Genome Guardian'." ScienceDaily. www.sciencedaily.com/releases/2007/10/071015215101.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins